Cancer
📧 Sign up to get email alerts when something new happens for Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Phase I Open-Label, Single-Arm, Dose-Escalation Clinical and Pharmacology Study of CCI-001 as Monotherapy and in Combination With Standard Chemotherapy in Patients With Recurrent and/or Metastatic Solid Tumours [Phase 1]
This is a Phase 1 open-label, dose-escalation study evaluating CCI-001 as monotherapy and in combination with standard chemotherapy for pati…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Sustaining Physical Activity After Cancer Exercise Sessions [NA]
A Colorado State University-sponsored clinical trial is studying strategies to sustain physical activity after cancer exercise programs; the…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Dyadic Life Review Intervention for Older Patients With Advanced Cancer) and Their Caregivers [NA]
A clinical trial evaluating a dyadic life review intervention for older patients with advanced cancer and their caregivers; recruitment is o…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs [NA]
A pediatric oncology caregiver study is evaluating meditation-based programs to reduce anxiety related to cancer imaging. The trial is curre…
-
EMA approval · 2026-03-18EMA Authorised: Akynzeo (netupitant;palonosetron hydrochloride) — Helsinn Birex Pharmaceuticals Ltd
EMA authorised Akynzeo, a fixed-dose combination of netupitant and palonosetron hydrochloride, for prevention of vomiting and nausea associa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-03-18EMA Authorised: Pelmeg (pegfilgrastim) — Mundipharma Corporation (Ireland) Limited
EMA authorised Pelmeg, a pegfilgrastim biosimilar by Mundipharma, to reduce the duration of neutropenia and the risk of febrile neutropenia …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Proof-of-Concept Study of the SNOEZELEN Device on Anxiety Symptoms in Patients Hospitalized for Chemotherapy in a Pediatric Oncology Department [NA]
Proof-of-concept study evaluating the Snoezelen multisensory device to reduce anxiety symptoms in children hospitalized for chemotherapy for…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Cancer Patient Empowerment Program: Phase 2 Feasibility Study [NA]
Phase 2 feasibility study of the Cancer Patient Empowerment Program, sponsored by the Nova Scotia Health Authority, has completed.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer [Phase 1]
Phase 1 clinical trial evaluating the safety and potential efficacy of psilocybin-assisted psychotherapy for demoralization syndrome in pati…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation [Phase 1]
A Phase 1 clinical trial evaluating virtual reality gaming for exercise and mindfulness in pediatric cancer rehabilitation has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Study of Elderly Patients With Cancer and Seen in Consultation of Geriatric Oncology in the Nord Pas-de-Calais (CONSOG).
This completed clinical trial study focuses on elderly cancer patients seen in geriatric oncology consultations in Nord Pas-de-Calais.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Telemedicine Rash Evaluation and Assessment of Toxicity in Skin in Acute Oncology and Haematology Care: A Pilot Study [NA]
A pilot study evaluating telemedicine-based rash evaluation and assessment of skin toxicity in cancer patients receiving systemic treatment …
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Single-Arm Interventional Trial of Pepper- Robot Delivered Cancer Education for Adults With Intellectual Disability [NA]
An interventional, single-arm trial is evaluating Pepper robot-delivered cancer education for adults with intellectual disabilities. The stu…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Clinical Study of BR105 Injection [Phase 1]
A Phase 1 clinical study of BR105 Injection for advanced malignancies has been terminated.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Exercise and Health Counseling in Pediatric Hematopoietic Stem Cell Transplantation [NA]
Clinical trial update describes a pediatric study examining exercise and health counseling for patients undergoing hematopoietic stem cell t…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: T Cell Receptor Gene-Engineered and Dominant Negative TGF-β Receptor T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor [Phase 1]
Phase 1 clinical trial update of a T cell receptor-engineered T cell therapy with a dominant negative TGF-β receptor targeting KRAS mutation…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001) [Phase 1]
Phase 1 trial of MK-4700 alone or with pembrolizumab in advanced or metastatic solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer [Phase 2]
A Phase 2 clinical trial comparing metronomic cyclophosphamide with megestrol acetate in palliative cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Evaluation of Oral Morphine Gel in Oral Mucositis Induced by Chemotherapy in Children and Young Adults [Phase 3]
A Phase 3 trial evaluating oral morphine gel for chemotherapy-induced oral mucositis in children and young adults was terminated.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001) [Phase 1]
A Phase 1 clinical trial of MK-8294 in participants with advanced solid tumors is underway, with recruitment currently ongoing.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) [Phase 1, Phase 2]
A Phase 1/2 study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of sotorasib (AMG 510) in KRAS G12C-mutant…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
The trial The TIOB is recruiting to collect cancer patient biospecimens for analysis of immunological and molecular biomarkers. It is sponso…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer [NA]
Completed Mayo Clinic trial evaluating targeted case management to improve functional status in patients with stage III-IV cancer. The docum…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Preliminary Study to the Manufacturing of a Non-stick Membrane for Surgery Using Patient's Own Cells (MESO-PATCH) [NA]
This clinical trial update reports a terminated study investigating MESO-PATCH, a non-stick surgical membrane made from the patient's own ce…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) [Phase 1]
Phase 1 study Beamion LUNG-1 evaluating multiple doses of Zongertinib in adults with advanced cancers harboring HER2 gene alterations, inclu…